Recent Food and Drug Administration (FDA) approval of diagnostic and therapeutic
radiopharmaceuticals and concurrent miniaturization of particle accelerators leading to …

This review demonstrates the progress in the synthesis of radioiodinated compounds over
the past decade. The possibilities and limitations of radiopharmaceuticals with different …

The prostate-specific membrane antigen (PSMA) has emerged as an attractive prostate
cancer associated target for radiotheragnostic application using PSMA-specific radioligands …

Modern medicine seeks precision targeting, imaging and therapy to maximize efficacy and
avoid toxicities. Nanoparticles (NPs) have tremendous yet unmet clinical potential to carry …

Theranostics, a promising modern concept combining diagnostic capabilities and
therapeutic effects, has been used for optimizing and personalizing the treatment of many …

Formyl peptide receptors (FPRs) comprise a class of chemoattractant pattern recognition
receptors, for which several physiological functions like host-defences, as well as the …

The high in vivo stability of 2, 2-dihydroxymethyl-3-[18F] fluoropropyl-2-nitroimidazole ([18F]
DiFA) prompted us to evaluate neopentyl as a scaffold to prepare a radiotheranostic system …

Immune checkpoint inhibitor (ICI) therapy has emerged as a major treatment option for a
variety of cancers. Among the immune checkpoints addressed, the programmed death …

Organic compounds bearing radioisotopes of iodine are widely used for biological research,
diagnostic imaging, and radiotherapy. Early reported synthetic methods for the incorporation …

The potential of designing irreversible alkyne-based inhibitors of cysteine cathepsins by
isoelectronic replacement in reversibly acting potent peptide nitriles was explored. The …